🇨🇦 15-methyl prostaglandin F2α in Canada

15-methyl prostaglandin F2α (15-methyl prostaglandin F2α) regulatory status in Canada.

Marketing authorisation

15-methyl prostaglandin F2α in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is 15-methyl prostaglandin F2α approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for 15-methyl prostaglandin F2α in Canada?

Brigham and Women's Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.